These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28291714)

  • 21. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
    Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes.
    Hegg RM; Schmit GD; Boorjian SA; McDonald RJ; Kurup AN; Weisbrod AJ; Callstrom MR; Atwell TD; Thompson RH
    J Urol; 2013 Apr; 189(4):1243-8. PubMed ID: 23123377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
    Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT
    AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis.
    Klatte T; Mauermann J; Heinz-Peer G; Waldert M; Weibl P; Klingler HC; Remzi M
    J Endourol; 2011 Jun; 25(6):991-7. PubMed ID: 21568698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. External validation of the ability of the mRENAL nephrometry score to identify patients at risk for major adverse events or local tumor recurrence after percutaneous renal cryoablation.
    Allen DM; Babar T; GloryAkinduro O; Li M; Khudari HE; Gunn AJ
    Abdom Radiol (NY); 2024 Aug; ():. PubMed ID: 39150544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.
    Hongo F; Yamada Y; Ueda T; Nakmura T; Naya Y; Kamoi K; Okihara K; Ichijo Y; Miki T; Yamada K; Ukimura O
    BMC Urol; 2017 Jan; 17(1):10. PubMed ID: 28100214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.
    Beksac AT; Rivera-Sanfeliz G; Dufour CA; Nseyo U; Hamilton Z; Berquist SW; Hassan AE; Raheem OA; Wang S; Wake RW; Gold RE; Derweesh IH
    World J Urol; 2017 Apr; 35(4):633-640. PubMed ID: 27484204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications.
    Rosenberg MD; Kim CY; Tsivian M; Suberlak MN; Sopko DR; Polascik TJ; Nelson RC
    AJR Am J Roentgenol; 2011 Apr; 196(4):935-9. PubMed ID: 21427348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes.
    Panumatrassamee K; Kaouk JH; Autorino R; Lenis AT; Laydner H; Isac W; Long JA; Eyraud R; Kassab A; Khalifeh A; Hillyer S; Rizkala E; Haber GP; Stein RJ
    J Urol; 2013 Mar; 189(3):818-22. PubMed ID: 23009872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
    J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 33. Image-guided percutaneous renal cryoablation: Five years experience, results and follow-up.
    Azevedo AAP; Rahal A; Falsarella PM; Lemos GC; Claros OR; Carneiro A; de Queiroz MRG; Garcia RG
    Eur J Radiol; 2018 Mar; 100():14-22. PubMed ID: 29496072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors.
    Buy X; Lang H; Garnon J; Sauleau E; Roy C; Gangi A
    AJR Am J Roentgenol; 2013 Dec; 201(6):1353-61. PubMed ID: 24261377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
    Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions.
    Papa M; Suardi N; Losa A; Agostini G; Maga T; Ierardi AM; Carrafiello G; Gaboardi F; Cardone G
    Med Oncol; 2020 Mar; 37(4):26. PubMed ID: 32166542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CT-Guided Microwave Ablation of 45 Renal Tumors: Analysis of Procedure Complexity Utilizing a Percutaneous Renal Ablation Complexity Scoring System.
    Mansilla AV; Bivins EE; Contreras F; Hernandez MA; Kohler N; Pepe JW
    J Vasc Interv Radiol; 2017 Feb; 28(2):222-229. PubMed ID: 27988263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting renal cryoablation complications: new risk score based on tumor size and location and patient history.
    Schmit GD; Schenck LA; Thompson RH; Boorjian SA; Kurup AN; Weisbrod AJ; Kor DJ; Callstrom MR; Atwell TD; Carter RE
    Radiology; 2014 Sep; 272(3):903-10. PubMed ID: 24814178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous Cryoablation for the Treatment of Recurrent Malignant Pleural Mesothelioma: Safety, Early-Term Efficacy, and Predictors of Local Recurrence.
    Abtin F; Quirk MT; Suh RD; Hsu W; Han SX; Kim GJ; Genshaft S; Sandberg JK; Olevsky O; Cameron RB
    J Vasc Interv Radiol; 2017 Feb; 28(2):213-221. PubMed ID: 27979596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort.
    Bhindi B; Thompson RH; Mason RJ; Haddad MM; Geske JR; Kurup AN; Hannon JD; Boorjian SA; Leibovich BC; Atwell TD; Schmit GD
    BJU Int; 2017 Jun; 119(6):905-912. PubMed ID: 28296030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.